Document:

Exhibit 10.39

 

*** Text Omitted and Filed Separately with the Secretary of the Commission

Confidential Treatment Requested

 

AMENDMENT No. 1 TO
 COMMERCIAL PACKAGING SERVICES AGREEMENT

 

THIS AMENDMENT NO. 1 (“Amendment”) by and between AMAG Pharmaceuticals, Inc. (“AMAG”), and Packaging Coordinators, LLC (“PCI”) is dated as of the 29th day of January, 2013 (“Effective Date”).

 

WHEREAS, AMAG and PCI (as successor by assignment to Catalent Pharma Solutions, LLC) are parties to a Commercial Packaging Services Agreement dated May 29, 2009 (the “Agreement”); and

 

WHEREAS, pursuant to Section 16.1 of the Agreement, the Agreement maybe amended by written amendment signed by the parties; and

 

WHEREAS, the parties desire to further amend the Agreement as set forth herein;

 

NOW, THEREFORE, the parties hereto, in consideration of the foregoing premises and the agreements herein contained and intending to be legally bound hereby, agree as follows:

 

1.                                      Definitions.  The capitalized terms in this Amendment which are not otherwise defined herein shall have their respective meanings set forth in the Agreement.

 

2.                                      Amendment to Agreement.  The Agreement is hereby amended as follows:

 

(a)                                 Section 1.3 shall be deleted in its entirety and replaced with the following:

 

“Applicable Laws” means all laws, ordinances, rules and regulations within the Territory applicable to the Packaging and Storage of the Product or any aspect thereof and the obligations of PCI or AMAG, as the context requires under this Agreement, including without limitation: (A) all applicable federal, state and local laws and regulations of each Territory, (B) the U.S. Federal Food, Drug and Cosmetic Act, and (C) the Good Manufacturing Practices (“GMPs”) promulgated by the Regulatory Authorities, as amended from time to time, as applicable to the Packaging and Storage.”

 

(b)                                 Section 1.14 shall be deleted in its entirety and replaced with the following:

 

“Regulatory Authority” means any governmental regulatory authority within a Territory involved in regulating any aspect of the development, manufacture, market approval, sale, distribution, packaging, storage or use of the Product.”

 

 

(c)                                  A new section 1.17 shall be added as follows: “Stored Product” means the Product once stored until used in connection with Packaging.  “Storage” means the storage of the Stored Product pursuant to the terms herein.”

 

(d)                                 Section 2.1 shall be amended by adding the following:

 

“PCI agrees to store any Product prior to Packaging at the Facility or at PCI’s facility at 2200 West Lakeshore Drive, Woodstock, IL 60098.  PCI shall store such Stored Product at a controlled temperature of between 20-25C.  PCI shall have three (3) days to inspect or otherwise evaluate each shipment of Product for external container or package damage or loss in transit and shall promptly notify AMAG of any damage observed.”

 

(e)                                  Section 3.6 shall be amended by adding a new paragraph as follows:

 

“For any Stored Product, AMAG agrees that: (A) title and risk of loss for such Stored Product will remain with AMAG during the storage period, and, upon use by PCI for Packaging, title and risk of loss will be governed as provided in this Agreement and (B) AMAG will be responsible for any decrease in value of such Stored Product other than as a result of PCI’s gross negligence or willful misconduct.  AMAG may request for return of the Stored Product, at its expense, at any time.  Notwithstanding anything herein to the contrary, PCI shall be responsible for any decrease in value to the Stored Product due its gross negligence or willful misconduct.”

 

(f)                                   Section 3.5, Article 6 (except Section 6.5), Section 8.1 and Section 8.2 shall be revised by adding “and Storage” wherever “Packaging” is mentioned and “and Stored Product” wherever “Packaged Product” is mentioned.

 

(g)                                  Section 6.5 shall be amended to add a new paragraph as follows:

 

“PCI shall be responsible for any Replacement Costs (as defined in Exhibit D) of Stored Product to the extent of any damage, loss, theft or destruction while on PCI premises due to the gross negligence or willful misconduct of PCI and not later than thirty (30) days following the end of each Contract Year, PCI shall provide AMAG with a detailed accounting of any damages, loss, theft or destruction of the Stored Product together with a payment representing the Replacement Cost for the losses of such Stored Product.”

 

(h)                                 There will be a new section 8.1 (D) as follows:

 

“The Product shall be stored and supplied in conformity with the Specifications, as applicable, and any written instructions by AMAG agreed to by PCI, which approval will not be unreasonably withheld or delayed.”

 

(i)                                     Section 11.1 shall be amended by adding “and Storage” after “Packaging” in Section 11.1(C).  Section 11.2 shall be amended by adding “Stored Product,”

 

2

 

after “use of or exposure to the Product,” in Section 11.2(B) and “and Storage” after “Packaging” in Section 11.2(C).

 

(j)                                    The parties acknowledge and agree that there will be a new separate and distinct Section 12.1(a) and 12.1(b) which will apply solely to PCI’s liability with respect to the Storage of the Product.  The original Section 12.1(a) and 12.1(b) continue to remain in full force and effect with respect to the Packaging.

 

(k)                                 Pricing for the Storage of Product shall be listed in Exhibit A, attached hereto and incorporated herein, and shall be subject to the payment provisions in Section 3.3.

 

(l)                                     All references in the Agreement to “Catalent” shall be amended to “PCI”.  PCI hereby acknowledges that it has assumed all of the rights, responsibilities and obligations formerly of Catalent under the Agreement.

 

(m)                             Any notices to PCI under Article 15 shall be provided to: Packaging Coordinators, LLC, 3001 Red Lion Road, Philadelphia, PA 19114, Attn: CEO, Facsimile: (215) 613-3127.

 

3.                                      Counterparts.  This Amendment No.  1 may be executed in counterparts, each of which shall be deemed an original, but which taken together shall constitute one and the same agreement.  The parties agree that a facsimile signature on the Amendment shall be binding evidence of a party’s signature (such facsimile which may also be forwarded by email).

 

4.                                      Effect of Agreement.  Except as amended hereby, all provisions of the Agreement are hereby ratified and shall continue in full force and effect and are incorporated herein by reference.  All references in the Agreement to “this Agreement” shall be deemed to refer to the Agreement, as amended by this Amendment.  This Amendment No. 1 shall be governed by and construed consistently with the terms of the Agreement.

 

[SIGNATURE PAGE FOLLOWS]

 

3

 

IN WITNESS WHEREOF, the undersigned have executed this Amendment as of the month and year first above written.

 

	
AMAG:
    	
 
    	
PCI:
    
	
 
    	
 
    	
 
    
	
AMAG   Pharmaceuticals, Inc.
    	
 
    	
Packaging   Coordinators, LLC
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
/s/   Scott T. McMillan
    	
 
    	
/s/   William A. Bolding
    
	
Signature
    	
 
    	
Signature
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
Scott   T. McMillan
    	
 
    	
William   A. Bolding
    
	
Print   Name
    	
 
    	
Print   Name
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
Senior   Vice President — Quality &
    	
 
    	
 
    
	
Technical   Operations
    	
 
    	
C.O.O.
    
	
Title
    	
 
    	
Title
    

 

 

 

Solution for

FerahemeTM bulk storage

VERSION: PS-KR10152012.02

 

Prepared for

 

Mr. Jim Lucie

61 Mooney Street

Cambridge, MA 02138

T (617) 576-4164

jlucie@amagpharma.com

 

Provided by

 

Packaging Coordinators Inc.

Ken Richardson

Account Director

3001 Red Lion Rd. Philadelphia, PA 19114

T (215) 397-5881

ken.richardson@pciservices.com

 

 

*** Text Omitted and Filed Separately with the Secretary of the Commission

Confidential Treatment Requested

 

November 19, 2012

 

Mr. Jim Lucie

61 Mooney Street

Cambridge, MA 02138

T (617) 576-4164

 

Dear Jim,

 

On behalf of Catalent Pharma Solutions, I am pleased to present the following quotation for bulk storage services for your product Feraheme.

 

The pricing in this quotation is based on the assumption that the product being stored at our facility will not require special handling.  For bulk product, finished product, API or excipients please supply the MSDS (Material Safety Data Sheet) for review and acceptance by our Product Review Committee.

 

	
Warehouse   Storage Fees
    	
 
    	
 
    
	
Project   Initiation
    	
 
    	
$[***]
    
	
Additional   Receipts
    	
 
    	
$[***]/lot/receipt
    
	
Monthly   Management Fee
    	
 
    	
$[***]/month
    
	
 
    	
 
    	
 
    
	
Storage
    	
 
    	
 
    
	
· Controlled   Room Temperature
    	
 
    	
$[***]/month/pallet
    
	
 
    	
 
    	
 
    
	
Importation   Management Fee (Initial)
    	
 
    	
$[***]   if we are importer of record
    
	
Importation   Management Fee (repeat-same drug)
    	
 
    	
$[***]
    
	
Custom   Broker Fee
    	
 
    	
$[***]
    
	
Freight/Airport   Storage (if applicable)
    	
 
    	
Cost   + [***]%
    
	
Duty   Fees
    	
 
    	
Cost
    

 

For services not included in above for example, additional audit assistance, material handling, etc.:

 

	
Hourly   Employee Rate
    	
 
    	
$[***]per   hour
    
	
Salaried   Employee Rate
    	
 
    	
$[***]per   hour
    

 

2

 

*** Text Omitted and Filed Separately with the Secretary of the Commission

Confidential Treatment Requested

 

	
Shipping and Handling (Ambient)
    
	
Shipping
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
· Domestic
    	
 
    	
$[***]/first   pallet/location/shipment + $[***]each additional pallets/same location/same   shipment
    
	
 
    	
 
    	
 
    
	
· Domestic — Bulk
    	
 
    	
$[***]/shipment
    
	
 
    	
 
    	
 
    
	
· International
    	
 
    	
$[***]/first   pallet/location/shipment + $[***]each additional pallet/same location/same   shipment
    
	
 
    	
 
    	
 
    
	
· International — Bulk
    	
 
    	
$[***]/shipment
    

 

	
Shipping and Handling (2-8°C)
    
	
Shipping
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
· Domestic
    	
 
    	
$[***]/first   pallet/location/shipment + $[***]each additional pallet/same location/same   shipment
    
	
 
    	
 
    	
 
    
	
· Domestic — Bulk
    	
 
    	
$[***]/shipment
    
	
 
    	
 
    	
 
    
	
· International
    	
 
    	
$[***]/first   pallet/location/shipment + $[***]each additional pallet/same location/same   shipment
    
	
 
    	
 
    	
 
    
	
· International — Bulk
    	
 
    	
$[***]/shipment
    
	
 
    	
 
    	
 
    
	
Freight and Shipping Supplies Additional — Cost +   [***]%
    
	
 
    	
 
    	
 
    
	
·      48 Hour Turnaround 
    	
 
    	
Shipping   Fee: Quoted Rate
    
	
·      Next Day Turnaround 
    	
 
    	
Shipping   Fee: Quoted Rate + [***]% Premium
    
	
·      Same Day Turnaround 
    	
 
    	
Shipping   Fee: Quoted Rate + [***]% Premium
    

 

PCI will require all dispatched shipments to be detailed in a Shipping Protocol.

 

PCI reserves the right to revisit pricing on an annual basis.

 

Standard Terms and Conditions

 

At the time of this quotation there is a Packaging Agreement dated 29 May 2009 as amended executed between Catalent Pharma Solutions, LLC and AMAG Pharmaceuticals, Inc and the terms and conditions of such Packaging Agreement will supersede this Quotation (including its Terms and Conditions) if such packaging agreement is still in force.

 

3

 

Cancellation:

Customer is responsible for all materials and tooling purchased on their behalf.

 

Payment Terms:

NET 30

If you have any questions concerning this quotation, please do not hesitate to contact me at [TELEPHONE].

 

	
Kind   Regards,
    	
 
    
	
 
    	
 
    
	

    	
 
    
	
 
    	
 
    
	
Ken   Richardson
    	
 
    
	
Account   Director, U.S. Commercial Packaging
    	
 
    
	
Packaging   Coordinators Inc.
    	
 
    

 

4

 

Project Approval and Authorization

 

By signing below, AMAG agrees to the project details as set forth in this Quotation.

 

	
AMAG
    	
 
    	
Packaging Coordinators Inc.
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
/s/   Jim Lucie
    	
 
    	
 
    	
/s/ Ken Richardson
    
	
Signature
    	
 
    	
 
    	
Signature
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    
	
Jim   Lucie
    	
 
    	
 
    	
Ken Richardson
    
	
Printed   Name
    	
 
    	
 
    	
Printed Name
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    
	
Sr.   Mgr Material Control
    	
 
    	
 
    	
Account Director
    
	
Title
    	
 
    	
 
    	
Title
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    
	
28   Nov 2012
    	
 
    	
 
    	
November 19, 2012
    
	
Date
    	
 
    	
 
    	
Date
    
	
 
    	
 
    	
 
    	
 
    
	
58354
    	
 
    	
 
    	
 
    
	
PO   Number
    	
 
    	
 
    	
 
    

 

Please sign and return a copy of the Quotation Approval Page via e-mail to

 Ken Richardson at [EMAIL]

 

5Exhibit 10.19

 

AMENDMENT TO EMPLOYMENT AGREEMENT

 

THIS AMENDMENT (the “Amendment”) is made by and between United Online, Inc., a Delaware corporation (the “Company”), and Paul E. Jordan (the “Employee”), effective as of January 25, 2013.

 

RECITALS

 

WHEREAS, the Company and the Employee entered into an Employment Agreement on February 7, 2011 (the “Agreement”); and

 

WHEREAS, the Company and the Employee now wish to amend the Agreement as set forth below.

 

NOW, THEREFORE, in consideration of the foregoing, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the undersigned, intending to be legally bound hereby, agree as follows:

 

1.             The third paragraph following Section 7(b)(III) of the Agreement is hereby amended and restated to read as follows:

 

If Employee’s employment is terminated by the Company “without cause” (as defined below) or if Employee terminates his employment with the Company for “good reason” (as defined below) during the Term and within the twenty-four (24) month period beginning on the effective date of a Qualifying Change in Control (as defined below), the Separation Payment to which Employee becomes entitled under this Section 7(b) or under Section 7(a) above upon Employee’s satisfaction of the Release Condition will be payable in a single lump-sum payment on the first regular payday for the Company’s salaried employees, within the sixty (60)-day period following the date of Employee’s “separation from service” (as defined below) as a result of Employee’s termination “without cause” (as defined below) or Employee’s resignation for “good reason” (as defined below), on which Employee’s executed Release is effective and enforceable in accordance with its terms following the expiration of the applicable revocation period in effect for that Release.  However, should such sixty (60)-day period span two taxable years, then such payment shall be made during the portion of that period that occurs in the second taxable year.  Any Separation Payment to which Employee becomes entitled hereunder in connection with a termination following a Change in Control other than a Qualifying Change in Control will be paid in installments as set forth in the immediately preceding paragraph of this Section 7(b).  For purposes of this Agreement, a “Change in Control” shall have the meaning assigned to such term in the Company’s 2010 Incentive Compensation Plan (or successor thereto), and a “Qualifying Change in Control” shall mean the date on which there occurs a “Change in Control” (as defined above)

 

 

that also qualifies as: (i) a change in the ownership of the Company, as determined in accordance with Section 1.409A-3(i)(5)(v) of the Treasury Regulations, (ii) a change in the effective control of the Company, as determined in accordance with Section 1.409A-3(i)(5)(vi) of the Treasury Regulations, or (iii) a change in the ownership of a substantial portion of the assets of the Company, as determined in accordance with Section 1.409A-3(i)(5)(vii) of the Treasury Regulations.  For the avoidance of doubt, if all or substantially all of the businesses or assets comprising the Company’s FTD segment, Communications segment or Content & Media segment are sold, spun off or otherwise disposed of in one or a series of related transactions, the consummation of such sale, spin-off or other disposition shall be deemed to be a Change in Control; provided, however, that (x) if all or substantially all of the businesses or assets of any two of Memory Lane, Inc. (i.e., the domestic business), StayFriends GmbH and MyPoints.com, Inc. are sold, spun off or otherwise disposed of in one or a series of related transactions, the consummation of such sale, spin-off or other disposition of any two of those businesses, in and of itself, shall be deemed to be a Change in Control, and (y) if all or substantially all of the Company’s MyPoints.com, Inc. business or assets are sold, spun off or otherwise disposed of in one or a series of related transactions, the consummation of such sale, spin-off or other disposition, in and of itself, shall not be deemed to be a Change in Control.

 

2.             Except as modified by this Amendment, the Agreement shall remain in full force and effect.

 

[Signature Page Follows]

 

2

 

IN WITNESS WHEREOF, the Company and the Employee have executed this Amendment, in the case of the Company by a duly authorized officer, as of the date stated in the opening paragraph.

 

 

	
UNITED   ONLINE, INC.
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
/s/ Mark R. Goldston
    	
 
    	
Date: January 25, 2013
    
	
By:
    	
Mark R. Goldston
    	
 
    	
 
    
	
 
    	
Chairman, President and Chief Executive Officer
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
EMPLOYEE
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
/s/ Paul E. Jordan
    	
 
    	
Date: January 25, 2013
    
	
Paul E. Jordan
    	
 
    	
 
    

 

3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00213-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00213-of-00352.parquet"}]]